Purchase Order SPE2DP24P0682

Award Date 8/6/24
Potential Completion Date 8/21/24
Potential Value $7.1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $82,417.09. The contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999. This IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract covers a wide range of pharmaceutical products, including common medications as well as specialized drugs and medical supplies, to fulfill the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) for use by the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract is a $46,732.08 firm fixed-price delivery order placed under a larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which runs through December 31, 2025. Through this...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a Firm Fixed Price Delivery Order valued at $2,798.95 with a period of performance through February 28, 2024. The award was made by the Defense Logistics Agency (DLA) and encompasses the supply of various pharmaceutical products, including medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. This Delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $11,849.81 under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) valued at up to $499,999,999. The IDC, which runs through December 31, 2025, allows the DLA to issue firm fixed-price delivery orders to DMS Pharmaceutical Group for a comprehensive range of pharmaceutical items, including both common and...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $1,027.95 under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC). The IDC, valued up to $499,999,999, enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide....
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $11,587.21. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to provide a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of various pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $18,568.80 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, which runs through December 31, 2025....
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB indefinite delivery contract (IDC) valued up to $499,999,999. The order, valued at $7,400.64, is for the supply of a wide range of pharmaceutical products, including both branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. These products are to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) as a firm fixed-price delivery order with no set-aside designation. The contract, valued at $13,511.28, is for the delivery of pharmaceutical items to support the medical supply needs of the Department of Defense (DoD) healthcare facilities. The award is associated with a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group...

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) on August 6, 2024. The $7,140.80 firm fixed-price purchase order (SPE2DP24P0682) is for the delivery of various pharmaceutical products, including meningococcal group vaccines, to support the medical supply needs of Department of Defense (DoD) healthcare facilities.

The contract has no set-aside designation and is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group's position as a prime vendor for pharmaceutical products and pharmacy services to the DoD solidifies its role as a crucial supplier in the federal pharmaceutical supply chain.

Generated 11/5/24, 9:11 AM